Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
31 January 2024 | Story EDZANI NEPHALELA | Photo ANJA AUCAMP
Dr Martin Laubscher
Dr Martin Laubscher’s thesis, crowned with the Andrew Murray-Desmond Tutu Prize, is testament to the university’s unwavering commitment to scholarly excellence.

In a historic triumph that reverberates over four decades since its inception, the UFS has clinched the coveted Andrew Murray Prize – now renamed the Andrew Murray-Desmond Tutu Prize – for the first time. Standing shoulder to shoulder with institutions such as the University of Pretoria (UP) and Stellenbosch University (SU), this achievement marks a significant milestone in the UFS’ journey.

At the heart of this accomplishment lies the profound contribution of Dr Martin Laubscher, distinguished Senior Lecturer specialising in Practical and Missional Theology in the Faculty of Theology and Religion. Dr Laubscher’s dedication and scholarly prowess culminated in the groundbreaking work titled Publieke teologie as profetiese teologie? (Public theology as prophetic theology), a revised edition of his doctoral thesis, which was originally crafted at Stellenbosch University in 2020, with a focus on the eminent Karl Barth.

Dr Laubscher received the Andrew Murray Prize for Theological Books in Afrikaans for his research and insightful analysis. The journey started when he realised, under the guidance of his study leader, Prof Dion Forster, that his script had the potential to be published in Afrikaans. Sun Media’s interest in publishing this work in Afrikaans, led to it being the first-ever published thesis in Afrikaans. Dr Laubscher recalls, “I was grateful and excited about Sun Media’s interest. The book emerged within a year, and during a celebratory launch Prof Forster suggested I submit it for the Andrew Murray Prize.”

Earlier this year, Dr Laubscher was excited to learn that he was being shortlisted for the prestigious award. Reflecting on the significant moment, he shares, “The elation I felt upon receiving the news was unparalleled. I was not only celebrating a personal triumph, but also etching my name as the first laureate from our faculty to secure this prestigious accolade.”

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept